NCT00801931 2019-03-27Double Cord Blood Transplant for Patients With Malignant and Non-malignant DisordersColumbia UniversityPhase 1/2 Terminated1 enrolled 8 charts
NCT01049854 2018-08-21CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor TransplantNew York Medical CollegePhase 2 Completed20 enrolled
NCT00301834 2017-09-28Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic DisordersUniversity of California, San FranciscoPhase 2 Completed35 enrolled 11 charts
NCT01191749 2017-05-09Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)M.D. Anderson Cancer CenterPhase 2 Terminated7 enrolled 6 charts
NCT00104975 2016-12-15Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerYale UniversityPhase 1 Completed20 enrolled
NCT00618969 2016-03-03Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related DonorsUniversity of ArizonaPhase 2 Completed2 enrolled
NCT00454480 2013-08-26Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesNational Cancer Institute (NCI)Phase 2/3 Completed2,000 enrolled